The most popular Heart Sisters article in 2024
Heart Sisters
DECEMBER 29, 2024
Was this particular article the most popular of 2024 because my HEART SISTERS readers aren't getting clear jargon-free, patient-friendly answers from their doctors?
Sun.Dec 29, 2024
75 
Have the New Pulmonary Hypertension Drugs Changed the Game?
Med Page Today
DECEMBER 29, 2024
(MedPage Today) -- In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this report, we follow up on what has happened since. After the FDA approved both combination macitentan/tadalafil.
Dizziness in a 40-something with recent stent for inferior OMI
Dr. Smith's ECG Blog
DECEMBER 29, 2024
Dizziness is so unlikely to be OMI without an obvious ECG, that I am going to pretend that this patient presented with chest pain. The PMCardio Queen of Hearts app asks you, before giving an interpretation of OMI ("STEMI-Equivalent"), whether the patient's clinical presentation is high risk for OMI. If no, then she will tell you that the case is outside of the intended use group.
Study of the effect of azithromycin on airway remodeling in asthma via the SAPK/JNK pathway
Journal of Cardiothoracic Surgery
DECEMBER 29, 2024
Asthma is a prevalent status attributing to lower respiratory tract chronic inflammation. Azithromycin (AZM) is known to be effective against asthma. Thus, this study delved into the mechanism of AZM repressin.
Psychiatry Year in Review: 2024
HCPLive
DECEMBER 29, 2024
This Year in Review features 2024 psychiatry highlights: FDA approvals, MDMA-assisted therapy setback, MM120 breakthrough, new CPT codes, and advances in schizophrenia treatments.
Therapeutic strategy and efficacy evaluation of chronic empyema after total pneumonectomy: individualized analysis of six patients
Journal of Cardiothoracic Surgery
DECEMBER 29, 2024
Chronic empyema after total pneumonectomy is a potentially fatal complication.The aim of the study is to explore the treatment strategy and clinical efficacy of chronic empyema after pneumonectomy.
Gastroenterology Year in Review: 2024
HCPLive
DECEMBER 29, 2024
This year in review spotlights top GI FDA news from 2024 and new clinical guidance from the American Gastroenterological Association.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Intraprocedural Transthoracic EChocardiography To Facilitate Left Bundle Branch Pacing: EC-LBBP
HeartRhythm
DECEMBER 29, 2024
Left bundle branch (LBB) pacing (P) has gained rapid adoption. Evidence for direct LBB capture has varied from 30-95% depending on the criteria.
Pitfalls of computed tomography angiography examination in veno-arterial extracorporeal membrane oxygenation patients: a case report of a patient with cardiac rupture
Journal of Cardiothoracic Surgery
DECEMBER 29, 2024
Veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO) is commonly used for patients with cardiac arrest, cardiogenic shock, or heart failure and is a life-saving technique. Computed tomography angiogr.
Incidence, Characteristics and Prognostic Significance of Early Recurrences Following Different Ablation Approaches for Persistent Atrial Fibrillation
HeartRhythm
DECEMBER 29, 2024
Early recurrence of atrial tachyarrhythmia (ERAT) is common following catheter ablation of atrial fibrillation (AF). The specific clinical and arrhythmia characteristics of ERAT influencing late recurrence risk in persistent AF is unclear. Additionally, the impact of different ablation strategies on the incidence and prognostic significance of ERAT remains unknown.
Prognostic value of albumin-bilirubin grade in lung cancer: a meta-analysis
Journal of Cardiothoracic Surgery
DECEMBER 29, 2024
Purpose To clarify the prognostic role of pretreatment albumin-bilirubin (ALBI) grade in lung cancer patients. Methods The PubMed, EMBASE, Web of Science and CNKI databases were searched up to April 20, 2024. Primary outcomes included the overall survival (OS), progression-free survival (PFS) and cancer-specific survival (CSS). Hazard ratios (HRs) with 95% confidence intervals (CIs) were combined and subgroup analysis based on the type of lung cancer [non-small cell lung cancer (NSCLC) vs. small
Left bundle branch block – innocent bystander, silent menace, or both
HeartRhythm
DECEMBER 29, 2024
Left bundle branch block (LBBB) causes immediate electrical and mechanical dys-synchrony of the left ventricle (LV) and gradual structural damages in the Purkinje cells and myocardium. Mechanical dys-synchrony reduces the LV ejection fraction (EF) instantly, but only to 55% in an otherwise normal heart. Because of the hearts in-built functional redundancy, a patient with LBBB does not always notice the hearts reduced efficiency straight away.
Let's personalize your content